Literature DB >> 26613671

CD4+ CD28-Negative Cells: Armed and Dangerous.

N Murakami1, L V Riella1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26613671      PMCID： PMC4966550          DOI： 10.1111/ajt.13646

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  9 in total

1.  CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells.

Authors:  L-M Charbonnier; B Vokaer; P H Lemaître; K A Field; O Leo; A Le Moine
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

2.  Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model.

Authors:  L V Riella; T Liu; J Yang; S Chock; T Shimizu; B Mfarrej; I Batal; X Xiao; M H Sayegh; A Chandraker
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

3.  IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.

Authors:  O Traitanon; A Gorbachev; J J Bechtel; K S Keslar; W M Baldwin; E D Poggio; R L Fairchild
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

4.  Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.

Authors:  Michelle Yap; Françoise Boeffard; Emmanuel Clave; Annaick Pallier; Richard Danger; Magali Giral; Jacques Dantal; Yohann Foucher; Cécile Guillot-Gueguen; Antoine Toubert; Jean-Paul Soulillou; Sophie Brouard; Nicolas Degauque
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

5.  Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.

Authors:  R W J Meijers; N H R Litjens; D A Hesselink; A W Langerak; C C Baan; M G H Betjes
Journal:  Am J Transplant       Date:  2015-07-24       Impact factor: 8.086

6.  Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease.

Authors:  Michiel G H Betjes; Martin Huisman; Willem Weimar; Nicolle H R Litjens
Journal:  Kidney Int       Date:  2008-07-09       Impact factor: 10.612

7.  High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept.

Authors:  S M Krummey; J A Cheeseman; J A Conger; P S Jang; A K Mehta; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2014-03       Impact factor: 8.086

8.  CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection.

Authors:  J Espinosa; F Herr; G Tharp; S Bosinger; M Song; A B Farris; R George; J Cheeseman; L Stempora; R Townsend; A Durrbach; A D Kirk
Journal:  Am J Transplant       Date:  2016-01-14       Impact factor: 8.086

9.  Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction.

Authors:  S Shabir; H Smith; B Kaul; A Pachnio; S Jham; S Kuravi; S Ball; S Chand; P Moss; L Harper; R Borrows
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086
  9 in total
  3 in total

Review 1.  Unusual CD4+CD28- T Cells and Their Pathogenic Role in Chronic Inflammatory Disorders.

Authors:  Ga Hye Lee; Won-Woo Lee
Journal:  Immune Netw       Date:  2016-12-22       Impact factor: 6.303

2.  Kidney Transplant Outcome Is Associated with Regulatory T Cell Population and Gene Expression Early after Transplantation.

Authors:  Magdalena Krajewska; Katarzyna Kościelska-Kasprzak; Dorota Kamińska; Marcelina Żabińska; Marta Myszka-Kozłowska; Agnieszka Gomułkiewicz; Piotr Dzięgiel; Marian Klinger
Journal:  J Immunol Res       Date:  2019-01-08       Impact factor: 4.818

3.  Longitudinal monitoring of mRNA levels of regulatory T cell biomarkers by using non-invasive strategies to predict outcome in renal transplantation.

Authors:  Angelica Canossi; Samuele Iesari; Quirino Lai; Simone Ciavatta; Tiziana Del Beato; Alessandra Panarese; Barbara Binda; Alessandra Tessitore; Franco Papola; Francesco Pisani
Journal:  BMC Nephrol       Date:  2022-02-02       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.